Scientist.com Partners With Top Pharma to Launch COMPLI, a Global Compliance Standard for Human Biosample Acquisition

Published on
September 21, 2017

SAN DIEGO, SEPTEMBER 21, 2017 (BUSINESS WIRE) - Scientist.com, the world's leading marketplace for outsourced scientific services, today announced the launch of a global process for the ethical sourcing of human biosamples using it’s COMPLI™ functionality.  Created in partnership with leading pharmaceutical companies, suppliers and biobank organizations such as the ESBB and UKCRC TCC, COMPLITM introduces a common, comprehensive process and supply agreement supporting access to human biosamples.  The goal is to enable biobanks and other well-known human sample suppliers to more easily connect with researchers in the pharmaceutical and biotech industries and academia. 

 

“By simplifying and standardizing processes that previously took months, this initiative should shorten the research cycle and increase the pace of research,” stated Dr Matharoo-Ball, President Elect, European Middle Eastern and African Society for Biopreservation and BioBanking (ESBB). “We are pleased to support the development of a standard process that allows us all to rapidly utilize correctly consented human biosamples in an ethically compliant manner.”

 

Human biological samples, such as organs, tissues and genetic material, are increasingly being used in drug research, but until now there has been no common process governing their acquisition.  The new COMPLI™ process helps researchers and suppliers adhere to internal and external (often legislative) procurement policies.  It also ensures that appropriate donor consents have been obtained, tracked and communicated throughout the supply chain.

 

“It is still possible today to purchase human biological samples without any oversight whatsoever, putting all parties at considerable risk if samples are used inappropriately,” stated Matt McLoughlin, Senior Director of Compliance at Scientist.com. “The launch of COMPLI™ will significantly reduce the risks associated with using human samples. It will also enable researchers to gain faster access to critical research tools needed to respond to global health emergencies.”

 

COMPLI™ establishes a rigorous compliance and governance framework that increases visibility, traceability and control for the scientific research community. It is only available through the Scientist.com marketplace.

Scientist.com

Scientist.comは、科学研究のアウトソーシングという複雑な業務のために構築された、世界最大かつ初のプラットフォームです。

‍

私たちは、製薬・バイオテクノロジー企業が、創薬や前臨床研究から臨床開発、製造、メディカルアフェアーズ、そして商業化に至るまで、パイプラインのあらゆる段階を支えるプロバイダーとの関係を構築、管理、拡大できるよう支援しています。一元化されたプラットフォームを通じて、組織は6,000社以上のグローバルなプロバイダーネットワークにアクセスし、調達ワークフローの効率化、コンプライアンスの維持、サプライヤー関係の管理を実現するとともに、データに基づいた洞察を活用して、より迅速かつ的確な意思決定を行うことが可能です。

‍

現在、Scientist.comは世界の製薬企業トップ30社のうち24社を含む130以上のライフサイエンス関連組織を支援しており、業務の複雑さを軽減し、開発期間を短縮し、イノベーションをより迅速に患者へ届けるためのサポートを行っています。私たちの使命は、2050年までに人類のあらゆる疾患を治癒可能にすることです。

このプレスリリースを共有する